Your browser doesn't support javascript.
loading
Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study.
Smyth, L J; Kilner, J; Nair, V; Liu, H; Brennan, E; Kerr, K; Sandholm, N; Cole, J; Dahlström, E; Syreeni, A; Salem, R M; Nelson, R G; Looker, H C; Wooster, C; Anderson, K; McKay, G J; Kee, F; Young, I; Andrews, D; Forsblom, C; Hirschhorn, J N; Godson, C; Groop, P H; Maxwell, A P; Susztak, K; Kretzler, M; Florez, J C; McKnight, A J.
Afiliación
  • Smyth LJ; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK. laura.smyth@qub.ac.uk.
  • Kilner J; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Nair V; Internal Medicine, Department of Nephrology, University of Michigan, Ann Arbor, MI, USA.
  • Liu H; Department of Department of Medicine/ Nephrology, Department of Genetics, Institute of Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Brennan E; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin 4, Ireland.
  • Kerr K; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Sandholm N; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Cole J; Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Dahlström E; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Syreeni A; Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Salem RM; Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.
  • Nelson RG; Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Looker HC; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Wooster C; Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Anderson K; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • McKay GJ; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
  • Kee F; Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Young I; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Andrews D; Department of Family Medicine and Public Health, UC San Diego, San Diego, CA, USA.
  • Forsblom C; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA.
  • Hirschhorn JN; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA.
  • Godson C; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Groop PH; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Maxwell AP; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Susztak K; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Kretzler M; Molecular Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Florez JC; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine, University College Dublin, Dublin 4, Ireland.
  • McKnight AJ; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Clin Epigenetics ; 13(1): 99, 2021 05 01.
Article en En | MEDLINE | ID: mdl-33933144
BACKGROUND: A subset of individuals with type 1 diabetes mellitus (T1DM) are predisposed to developing diabetic kidney disease (DKD), the most common cause globally of end-stage kidney disease (ESKD). Emerging evidence suggests epigenetic changes in DNA methylation may have a causal role in both T1DM and DKD. The aim of this exploratory investigation was to assess differences in blood-derived DNA methylation patterns between individuals with T1DM-ESKD and individuals with long-duration T1DM but no evidence of kidney disease upon repeated testing to identify potential blood-based biomarkers. Blood-derived DNA from individuals (107 cases, 253 controls and 14 experimental controls) were bisulphite treated before DNA methylation patterns from both groups were generated and analysed using Illumina's Infinium MethylationEPIC BeadChip arrays (n = 862,927 sites). Differentially methylated CpG sites (dmCpGs) were identified (false discovery rate adjusted p ≤ × 10-8 and fold change ± 2) by comparing methylation levels between ESKD cases and T1DM controls at single site resolution. Gene annotation and functionality was investigated to enrich and rank methylated regions associated with ESKD in T1DM. RESULTS: Top-ranked genes within which several dmCpGs were located and supported by functional data with methylation look-ups in other cohorts include: AFF3, ARID5B, CUX1, ELMO1, FKBP5, HDAC4, ITGAL, LY9, PIM1, RUNX3, SEPTIN9 and UPF3A. Top-ranked enrichment pathways included pathways in cancer, TGF-ß signalling and Th17 cell differentiation. CONCLUSIONS: Epigenetic alterations provide a dynamic link between an individual's genetic background and their environmental exposures. This robust evaluation of DNA methylation in carefully phenotyped individuals has identified biomarkers associated with ESKD, revealing several genes and implicated key pathways associated with ESKD in individuals with T1DM.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Metilación de ADN / Epigénesis Genética / Diabetes Mellitus Tipo 1 / Nefropatías Diabéticas / Fallo Renal Crónico Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Epigenetics Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Metilación de ADN / Epigénesis Genética / Diabetes Mellitus Tipo 1 / Nefropatías Diabéticas / Fallo Renal Crónico Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Epigenetics Año: 2021 Tipo del documento: Article